Phase 1RecruitingNCT06338553
GLP-1RA added around teplizumab in stage-2 T1D
Vanderbilt pilot study testing oral semaglutide/Rybelsus metabolic effects in people at early T1D stages receiving clinical teplizumab treatment.
Primary endpoints
- Impact on postprandial glycemia
- Impact on disposition index
- Endothelial-function measures
Results so far
No results posted yet.